North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by 2031. The North America In Vitro Diagn ...

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031. The global in vitro diagnostics (IVD) market encompasses a wide range of ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Capcom announced the release of a PC benchmark application on February 5, 2025.The application, titled “Monster Hunter Wilds Benchmark,” is designed as a diagnostic tool to evaluate the performance of ...

Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the US Food and Drug Administration (FDA) has cleared the ...

Hach proudly introduces the NH6000sc ammonia analyzer to the North American market, built with trusted Gas Sensing Electrode (GSE) technology to deliver six months of uninterrupted operation with 30% ...

Today's Research Daily features the Q4 earnings season scorecard and updated analyst reports on 16 major stocks, including Meta Platforms (META), Mastercard (MA) and Adobe (ADBE), as well as two micro ...

Ben Swindlehurst, CEO of Asset Disposal, a leading name in the IT asset management sector, is thrilled to announce the launch ...

A leading fund manager expects strong growth from these ASX small-cap stocks in 2025. The post 3 ASX small-cap shares with a 'solid growth outlook' for 2025 appeared first on The Motley Fool Australia ...

Chicago Partners Investment Group LLC acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the 4th ...

Revvity (NYSE:RVTY – Get Free Report) had its price target upped by Barclays from $135.00 to $140.00 in a research report ...